Hexima (ASX:HXL) EV-to-EBIT

: -0.34 (As of Today)

View and export this data going back to 2020. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Hexima's Enterprise Value is A$0.26 Mil. Hexima's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.75 Mil. Therefore, Hexima's EV-to-EBIT for today is -0.34.

The historical rank and industry rank for Hexima's EV-to-EBIT or its related term are showing as below:

ASX:HXL' s EV-to-EBIT Range Over the Past 10 Years
Min: -9.7 Med: 0 Max: 5.45
Current: -0.34

During the past 7 years, the highest EV-to-EBIT of Hexima was 5.45. The lowest was -9.70. And the median was 0.00.

ASX:HXL's EV-to-EBIT is ranked worse than
100% of 444 companies
in the Biotechnology industry
Industry Median: 8.185 vs ASX:HXL: -0.34

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Hexima's Enterprise Value for the quarter that ended in Dec. 2023 was A$1.09 Mil. Hexima's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.75 Mil. Hexima's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -68.85%.

Hexima EV-to-EBIT Historical Data

The historical data trend for Hexima's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hexima Annual Data

Trend

Jun08

Jun09

Jun10

Jun20

Jun21

Jun22

Jun23

EV-to-EBIT

Get a 7-Day Free Trial

-2.80

-0.11

-0.70

Hexima Semi-Annual Data
	Dec06	Dec07	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial										-	-0.11	-	-0.70	-

Competitive Comparison

For the Biotechnology subindustry, Hexima's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hexima EV-to-EBIT Distribution

For the Biotechnology industry and Healthcare sector, Hexima's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Hexima's EV-to-EBIT falls into.

Hexima EV-to-EBIT Calculation

Hexima's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	0.259	/	-0.753
	=	-0.34

Hexima's current Enterprise Value is A$0.26 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hexima's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.75 Mil.

Hexima (ASX:HXL) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Hexima's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-0.753	/	1.09372
	=	-68.85 %

Hexima's Enterprise Value for the quarter that ended in Dec. 2023 was A$1.09 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hexima's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.75 Mil.

Hexima EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Hexima's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Hexima (ASX:HXL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hexima Ltd (ASX:HXL) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

84-90 Hotham Street, Corporate One, Preston, VIC, AUS, 3072

Website

https://www.hexima.com.au

Hexima Ltd is a biotechnology company. The company is engaged in the research and development of plant-derived proteins and peptides for applications as human therapeutics.